Interpretation of Updates for Imaging Diagnosis in Guidelines for the Diagnosis and Treatment of Primary Liver Cancer(2024 Edition)--Focusing on Imaging Diagnosis of Subcentimeter Hepatocellular Carcinoma
10.3969/j.issn.1005-5185.2024.06.001
- VernacularTitle:《原发性肝癌诊疗指南(2024年版)》影像诊断更新解读——聚焦亚厘米肝癌的诊断
- Author:
Shengxiang RAO
1
;
Lan ZHANG
Author Information
1. 复旦大学附属中山医院放射科,上海 200032
- Keywords:
Carcinoma,hepatocellular;
Magnetic resonance imaging;
Diffusion-weighted imaging;
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid;
Diagnosis;
Guide;
Interpretation
- From:
Chinese Journal of Medical Imaging
2024;32(6):529-532
- CountryChina
- Language:Chinese
-
Abstract:
Since the publication of guidelines for diagnosis and treatment of primary liver cancer by National Health Commission of the People's Republic of China in 2017,which were updated in 2019 and 2022.The new version of the guidelines(2024 edition)has been published,which aims to early diagnosis,treatment and improvement of survival rate for patients with hepatocellular carcinoma.Imaging is essential for early diagnosis of hepatocellular carcinoma and the new guidelines feature major changes in the imaging techniques for early diagnosis of subcentimeter hepatocellular carcinoma(diameter≤1.0 cm),which were interpretated in this article.
